Company: CL
Filing Date: 2025-04-28
Form Type: 424B2
Source: 0001104659-25-039840
Chunk: 6

Company: COLGATE PALMOLIVE CO
Filing Date: 2025-04-28
Form: 424B2
Chunk 6
---
        | We intend to use the net proceeds from this offering for general corporate purposes.                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Additional Notes       | We may, from time to time, without the consent of or notice to existing holders of the Notes, create and issue further debt securities having the same terms and conditions as the Notes in all respects, except for the issue date, issue price and, in some cases, the first interest payment date and the initial interest accrual date. Additional debt securities issued in this manner will be consolidated with and will form a single series of debt securities with the previously outstanding Notes. |
| No Public Market       | The Notes are a new issue of securities with no established trading market. We do not intend to apply for the listing of the Notes on any securities exchange or for the quotation of the Notes on any automated dealer quotation system. The underwriters have advised us that they intend to make a market in the Notes, but they are not obligated to do so and may discontinue any market making at any time without notice.                                                                               |
| Trustee                | The Bank of New York Mellon                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

<div align='center'>S-2</div>

| Book-Entry    | The Notes will be issued in book-entry form and will be represented by one or more global notes deposited with, or on behalf of, a nominee of DTC. Investors may elect to hold interests in the Notes through Clearstream or Euroclear, which in turn will hold interests in the Notes in their capacity as participants at DTC. The Notes will be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. |
| Risk Factors  | See “Risk Factors” and the other information included in or incorporated by reference into this prospectus supplement and the accompanying prospectus for a discussion of factors you should carefully consider before deciding to purchase the Notes.                                                                                                                                                                                           |
| Governing Law | New York                                                                                                                                                                                                                                                                                                                                                                                                                                         |

<div align='center'>S-3

Risk Factors</div>

Your investment in the Notes involves certain risks. In consultation with your own financial, tax, accounting and legal advisers, you should carefully consider, among other matters, the factors set forth below as well as the risk factors discussed in the accompanying prospectus and in our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are incorporated by reference into this prospectus supplement and the accompanying prospectus before deciding whether to make an investment in the Notes.

Risks Related